The Federal Trade Commission claimed Walmart received unfair pricing advantages from PepsiCo, according to the newly unsealed complaint for the government’s lawsuit against PepsiCo that was dismissed ...

If Monday’s Supreme Court argument is any indication, the days of “independent” agencies acting as a fourth branch of government are numbered. In Trump v. Slaughter, a solid majority of the justices ...

Andrew Ferguson has used the Federal Trade Commission’s consumer protection mandate to investigate issues important to President Trump and his base. By David McCabe Reporting from Washington In July, ...

In November 2025, social media users (archived) began posting screenshots (archived) of an email purportedly from PayPal (archived) about money they had apparently received from an "FTC Prime ...

Amazon Prime subscribers who signed up for the Amazon-Federal Trade Commission settlement could have their money in their bank accounts this week. On Sept. 25, Amazon settled a two-year civil suit ...

Amazon Prime subscribers who signed up for the Amazon-Federal Trade Commission settlement could have their money in their bank accounts this week. On Sept. 25, Amazon settled a two-year civil suit ...

"The Court ultimately concludes that the agency has not carried its burden: Meta holds no monopoly in the relevant market," U.S. District Chief Judge James Boasberg wrote in a decision granting ...

A federal judge on Tuesday ruled in favor of Meta as it fought a Federal Trade Commission antitrust challenge of its acquisitions of Instagram and WhatsApp. In a lengthy ruling, U.S. District Judge ...

U.S. Senator Ron Wyden and Representative Raja Krishnamoorthi are urging the Federal Trade Commission (FTC) to investigate Flock Safety, saying the fast-growing surveillance technology company has ...

Staff at the US Federal Trade Commission said it appears Novo Nordisk A/S’ proposed bid for Metsera Inc. “may violate the procedural provisions” of the law that requires a premerger review. In a ...

As Novo Nordisk and Pfizer vie for control of Metsera, a new round of takeout proposals has resulted in the obesity biotech declaring Novo's offer "superior"—even though it has already inked an ...